ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Geriatric Medicine

Top Geriatric Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PAUL SOVRAN MD

Geriatric Medicine

4,206

$275K

273
257 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

IKE LEE M.D.

Geriatric Medicine

3,866

$263K

293
263 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $56

MARY COLBURN MD

Geriatric Medicine

3,836

$256K

236
234 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $56

JANE KIENLE MD

Geriatric Medicine

3,115

$249K

202
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$80
Average prescription price

Avg: $56

PEDRO HERNANDEZ-RIOS MD

Geriatric Medicine

10,437

$248K

480
443 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$24
Average prescription price

Avg: $56

ALAN GOLDBLATT M.D.

Geriatric Medicine

4,036

$245K

237
227 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $56

VASYL KASIYAN M.D.

Geriatric Medicine

5,517

$244K

229
209 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $56

DAVID BLOOM M.D.

Geriatric Medicine

6,319

$240K

904
870 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$38
Average prescription price

Avg: $56

ANN WEBER MD

Geriatric Medicine

3,875

$237K

353
343 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $56

TULAY DARSTEK MD

Geriatric Medicine

3,705

$215K

238
234 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $56

KIMBERLEY EVANS M.D.

Geriatric Medicine

3,638

$211K

243
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $56

MARGARET THEODORE M.D.

Geriatric Medicine

3,194

$204K

180
150 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $56

CESAR FERNANDEZ PEDEMONTE M.D.

Geriatric Medicine

3,930

$193K

445
347 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $56

MORRIS KUTNER M.D.

Geriatric Medicine

3,588

$186K

167
107 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

28%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $56

SUSAN RODELL M.D.

Geriatric Medicine

3,080

$185K

236
216 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $56

ANNA MARIE TRONCALES MD

Geriatric Medicine

4,223

$184K

434
317 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $56

ROBERT KAPLAN M.D.

Geriatric Medicine

3,398

$178K

67
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $56

REINALDO CAMARGO MD

Geriatric Medicine

3,416

$173K

385
332 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $56

JOHN FLEMING M.D.

Geriatric Medicine

2,625

$171K

172
122 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

JASPREET PESTANA MD

Geriatric Medicine

2,637

$158K

155
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $56

RAYMOND MOLANO MD

Geriatric Medicine

3,217

$150K

412
383 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $56

RENUKA TUNUGUNTLA M.D.

Geriatric Medicine

3,281

$147K

134
129 are 65+

21%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $56

LUIS BOBEICA M.D.

Geriatric Medicine

2,919

$145K

89
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $56

R BONILLA M.D.

Geriatric Medicine

1,812

$141K

130
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$78
Average prescription price

Avg: $56

BERNARD JASMIN MD

Geriatric Medicine

3,123

$139K

159
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank